Signaling pathways
-
BA6915 VU6036720Summary: VU6036720 is a potent and specific in vitro inhibitor. - BA6916 JNc-440Summary: JNc-440 is a potent antihypertensive agent.
- BA6917 CibenzolineSummary: Cibenzoline is a potent channel inhibitor that directly affects the pore-forming Kir6.2 subunit but not the SUR1 subunit.
- BA6918 AllocryptopineSummary: Allocryptopine is a derivative of yanhuisoetin.
- BA6919 DMP-543Summary: DMP-543 (XR-543) is a potassium channel blocker.
- BA6921 3-ChlorodiphenylamineSummary: 3-Chlorodiphenylamine is a high-affinity cardiac Ca sensitizer.
- BA6922 PK-THPPSummary: PK-THPP is an effective (for TASK-3 and TASK-1, s of 35 nM and 300 nM, respectively).
- BA6923 FoslevcromakalimSummary: Foslevcromakalim (QLS-101) is a sensitive potassium channel opener.
- BA6924 MK-8153Summary: MK-8153 is a potent, selective and orally active inhibitor of extrarenal medullary potassium channels with values of 5 nM and 34 μM for ROMKEP and hERGEP, respectively.
- BA6925 RA-2Summary: RA-2 is a negative gating regulator.